SCHEMBL17522467

SCHEMBL17522467

CC(C)(C)OC(=O)Nc1ccccc1C#C[Si](C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
HSD17B10 Q99714 1/20 0.52
BRD9 Q9H8M2 1/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
METAP1 P53582 1/20 0.41
TTK P33981 1/20 0.39
BRD4 O60885 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21046990 0.87 HSP90AA1 (0.40) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL29683128 0.87 HSP90AA1 (0.40) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL3394438 0.81 LMNA (0.46) BRD9LMNAPOLBRXFP1METAP1
SCHEMBL5776777 0.80 METAP1 (0.49) BRD9LMNAPOLBRXFP1METAP1
SCHEMBL1063858 0.80 NAMPT (0.45) MEN1KMT2AALDH1A1MAPTBRD9
SCHEMBL24110547 0.80 LMNA (0.48) BRD9LMNAPOLBRXFP1METAP1
SCHEMBL4774446 0.80 PDK1 (0.57) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL30914163 0.80 PDK1 (0.57) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL3053094 0.79 ALDH1A1 (0.60) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL15912303 0.79 KDM4E (0.60) MEN1KMT2AKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779568-B2 Autotaxin inhibitor compounds SABRE THERAPEUTICS LLC (US) 2023-10-10 US disclosed
US-11779568-B2 Autotaxin inhibitor compounds SABRE THERAPEUTICS LLC (US) 2023-10-10 US disclosed
US-11344533-B2 Autotaxin inhibitor compounds SABRE THERAPEUTICS LLC (US) 2022-05-31 US disclosed
US-20200268713-A1 AUTOTAXIN INHIBITOR COMPOUNDS DF 2024 IP ACQUISITION, LLC 2020-08-27 US disclosed
US-10688081-B2 Autotaxin inhibitor compounds SABRE THERAPEUTICS LLC (US) 2020-06-23 US disclosed
US-9999615-B2 Autotaxin inhibitor compounds PHARMAKEA, INC. (US) 2018-06-19 US disclosed
US-9999615-B2 Autotaxin inhibitor compounds PHARMAKEA, INC. (US) 2018-06-19 US disclosed
US-9714240-B2 Vinyl autotaxin inhibitor compounds PHARMAKEA, INC. (US) 2017-07-25 US disclosed
US-20160374991-A1 AUTOTAXIN INHIBITOR COMPOUNDS DF 2024 IP ACQUISITION, LLC 2016-12-29 US disclosed
US-9468628-B2 Autotaxin inhibitor compounds PHARMAKEA, INC (US) 2016-10-18 US disclosed
US-20160235713-A1 AUTOTAXIN INHIBITOR COMPOUNDS DF 2024 IP ACQUISITION, LLC 2016-08-18 US disclosed
US-20160222000-A1 VINYL AUTOTAXIN INHIBITOR COMPOUNDS DF 2024 IP ACQUISITION, LLC 2016-08-04 US disclosed
US-9334261-B2 Autotaxin inhibitor compounds PHARMAKEA, INC. (US) 2016-05-10 US disclosed
US-20160046614-A1 AUTOTAXIN INHIBITOR COMPOUNDS DF 2024 IP ACQUISITION, LLC 2016-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160374991-A1 AUTOTAXIN INHIBITOR COMPOUNDS ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885
US-11779568-B2 Autotaxin inhibitor compounds ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885
US-20160046614-A1 AUTOTAXIN INHIBITOR COMPOUNDS ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885
US-10688081-B2 Autotaxin inhibitor compounds ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885
US-11344533-B2 Autotaxin inhibitor compounds ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885
US-20200268713-A1 AUTOTAXIN INHIBITOR COMPOUNDS ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885
US-20160222000-A1 VINYL AUTOTAXIN INHIBITOR COMPOUNDS ENPP2, SERPINB1, SERPINB10 MEN1 910/4885KMT2A 1696/4885KDM4E 2416/4885
US-20160235713-A1 AUTOTAXIN INHIBITOR COMPOUNDS ENPP2, SERPINB1, SERPINE1 MEN1 737/4885KMT2A 2780/4885KDM4E 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.